APA (7th ed.) Citation

Yuma Ito, Masaki Fukui, Mamoru Kanda, Ko Morishita, Yoshimichi Shoji, Tatsuya Kitao, . . . Hiroaki Shirahase. (2018). Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice. Elsevier.

Chicago Style (17th ed.) Citation

Yuma Ito, Masaki Fukui, Mamoru Kanda, Ko Morishita, Yoshimichi Shoji, Tatsuya Kitao, Eiichi Hinoi, and Hiroaki Shirahase. Therapeutic Effects of the Allosteric Protein Tyrosine Phosphatase 1B Inhibitor KY-226 on Experimental Diabetes and Obesity via Enhancements in Insulin and Leptin Signaling in Mice. Elsevier, 2018.

MLA (9th ed.) Citation

Yuma Ito, et al. Therapeutic Effects of the Allosteric Protein Tyrosine Phosphatase 1B Inhibitor KY-226 on Experimental Diabetes and Obesity via Enhancements in Insulin and Leptin Signaling in Mice. Elsevier, 2018.